Cite
HARVARD Citation
Cousins, M. et al. (2013). The Safety and Efficacy of KAI‐1678— An Inhibitor of Epsilon Protein Kinase C (εPKC)—Versus Lidocaine and Placebo for the Treatment of Postherpetic Neuralgia: A Crossover Study Design. Pain medicine. 14 (4), pp. 533-540. [Online].